Redmile Group

Venture Capital

Healthcare-focused hedge fund and crossover investor backing biotech, therapeutics, and life sciences companies from early stage to public markets.

San Francisco, United States · 59+ investments · 46 portfolio companies

Seed
Early Stage
Growth
Late Stage
Biotech
Healthcare
Life Sciences
Therapeutics
Headquarters
San Francisco, United States
Founded
2007
AUM
$1.4B
Portfolio Companies
46
Total Investments
59
Last Investment
Jul 2025
Geographic Focus
United States

Investment Thesis

Healthcare-specialist crossover fund investing across the continuum from early venture to public biotech and life sciences companies.

Redmile Group is a Venture Capital firm based in San Francisco, United States. It has made 59 investments in Biotech and Healthcare, including Neuron23, Genalyte and Abcuro.

Portfolio46

Co-investors24

Sign up to view co-investors

24 co-investors across 103 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×12 · Other ×4 · Hedge Fund ×4 · 88 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Redmile Group on Indexed.vc
<a href="https://indexed.vc/investors/redmile-group"><img src="https://indexed.vc/api/badge/investor/redmile-group" alt="Redmile Group on Indexed.vc" width="260" height="76" /></a>